Quantcast

Latest biopharmaceutical Stories

2014-03-20 16:26:50

All amounts are in US dollars QUEBEC CITY, March 20, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology, today reported financial and operating results as at and for the fourth quarter and the year ended December 31, 2013. Revenues for the year ended December 31, 2013 were $6.2 million compared to $2.1 million for the same period in...

2014-03-18 16:25:29

JUPITER, Fla., March 18, 2014 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding its new project, "OPTIBIOCAT - Optimized esterase biocatalysts for cost-effective industrial production", an EU-funded project aimed at developing...

2014-03-18 08:32:43

-- ABRAXANE plus gemcitabine approved by the TGA for the first-line treatment of metastatic pancreatic cancer MELBOURNE, Australia, March 18, 2014 /PRNewswire/ -- Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased to announce that ABRAXANE(®) (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine in now approved by the Therapeutic Goods Administration (TGA) for the first-line treatment of metastatic pancreatic cancer. The TGA approved...

2014-03-16 16:20:46

CAMBRIDGE, England, March 16, 2014 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust Sanger Institute, announced today the publication in Nature Biotechnology of a paper describing its breakthrough therapeutic antibody discovery technology, Kymouse(TM) (http://dx.doi.org). Scientists at Kymab have engineered a mouse with the full set of genes encoding the human antibody repertoire, calling this...

2014-03-14 12:28:10

GHENT, Belgium, March 14, 2014 /PRNewswire/ -- ActoGeniX NV, creator of ActoBiotics(TM), announced today that Bernard Coulie, Chief Executive Officer, will present a company overview at the 21(st )Annual Future Leaders in the Biotech Industry Conference at 1:30pm ET on Friday, March 28, 2014, at the Millennium Broadway Hotel in New York City. A live webcast of the presentation will be available at the following link: https://www.webcaster4.com/Webcast/Page/392/3742 and on the...

2014-03-13 08:28:48

MONROVIA, Calif., March 13, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will release fourth quarter and full year 2013 financial results after market close on Wednesday, March 19, 2014. Xencor management will host a webcast and conference call the same day at 4:30 p.m. EDT (1:30 p.m. PDT) to...

2014-03-11 08:29:53

Funding to support clinical development of treatments for rare cholestatic liver diseases and nonalcoholic steatohepatitis SAN DIEGO, March 11, 2014 /PRNewswire/ -- Lumena Pharmaceuticals (Lumena), a biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, today announced that it has secured $45 million in Series B financing. New Enterprise Associates (NEA) led the financing,...

2014-03-10 16:30:46

LONDON, March 10, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Microfluidic Technologies: Biopharmaceutical and Healthcare Applications 2013-2023Report DetailsMicrofluidics - how to find trends, opportunities and revenue prospectsDo you want to assess the potential of microfluidic technologies? Visiongain's new report gives you revenue predictions there from 2013, helping you stay ahead. You find financial data, trends, opportunities, and...

2014-03-06 12:27:36

LONDON, March 6, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Biotechnology Products Markets in China China's demand for biotechnology products has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major...

2014-02-28 23:04:47

The 2014 BioProcess International Awards celebrate the excellence and innovation developed by those working in the biotherapeutic development and manufacturing industry. Nominations are open until June 27, 2014. New York, NY (PRWEB) February 28, 2014 BioProcess International (BPI), a business-to-business publication dedicated to delivering cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics, announces a Call for Nominations for the...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related